Atheroma or ischemia: which is more important for managing patients with stable chest pain?

Area of Science:

• Cardiology
• Cardiovascular Imaging
• Interventional Cardiology

Background:

• Stable chest pain, also known as chronic coronary syndrome, requires careful management decisions.
• Treatment strategies involve optimal medical therapy alone or combined with revascularization.
• Accurate assessment of coronary atheroma and myocardial ischemia is crucial for prognosis and symptom management.

Purpose of the Study:

• To review the impact of anatomical and physiological assessments in chronic coronary syndrome.
• To guide optimal and tailored therapy for patients with stable chest pain.
• To inform clinical decision-making regarding revascularization versus optimal therapy alone.

Main Methods:

• Review of current literature on anatomical and physiological assessment techniques.
• Analysis of the role of coronary atheroma burden and myocardial ischemia in treatment selection.
• Evaluation of evidence supporting different management strategies.

Main Results:

• Both anatomical (e.g., coronary angiography) and physiological (e.g., fractional flow reserve) assessments provide valuable information.
• The degree of coronary atheroma and ischemia significantly influences symptom severity and long-term prognosis.
• Tailored therapy based on comprehensive assessment improves patient outcomes.

Conclusions:

• Integrating anatomical and physiological data is essential for personalized management of chronic coronary syndrome.
• Informed decisions on revascularization can optimize patient care and prognosis.
• This approach facilitates tailored therapeutic strategies for stable chest pain patients.